Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease

Wiener Klinische Wochenschrift

Volumn 108, Issue 4, 1996, Pages 111-116

  Gryglewski, R J ^a,b   Grodzinska L ^a   Kostka Trabka E ^a   Korbut, R ^a   Bieron K ^a   Goszcz, A ^a   Slawinski M ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

atherosclerosis; cGMP levels; fibrinolysis; L arginine, nitric oxide; peripheral arterial obstructive disease; platelet aggregability; vasodilatation

Indexed keywords

ARGININE; CYCLIC GMP; NITRIC OXIDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; FIBRINOLYSIS; HUMAN; HYPERCHOLESTEROLEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIMB ISCHEMIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; VASODILATATION;

ADULT; AGED; ARGININE; ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXERCISE TEST; FEMALE; FIBRINOLYSIS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NITRIC OXIDE; PLATELET AGGREGATION; VASODILATOR AGENTS;

EID: 0029933180     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Agostini A, Marasini B, Biondi ML, Bassani C, Cazzaniga A, Potasso B (1991) L-arginine therapy in Raynaud's phenomenon. Int J Clin Lab Res 21: 202-203
2. Baudouni SV, Bath P, Martin JF, Dubois R, Evans TW (1993) L-arginine infusion has no effect on systemic haemodynamics in normal volunteers or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance. Br J Clin Pharmacol 36: 45-49
3. Bieroń K, Grodzińska L, Kostka-Tra̧bka E, Gryglewski RJ (1993) Prostacyclin and molsidomine synergise in their fibrinolytic and antiplatelet actions ex vivo in patients with peripheral arterial disease. Wien Klin Wochenschr 105: 7-11
4. Born GRV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929
5. Cayatte AJ, Palacino JJ, Horten K, Cohen RA (1994) Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14: 753-759
6. Cooke JP, Tsao PS (1994) Is NO an endogenous antiatherogenic molecule? Atheroscler Thromb 14: 653-655
7. Craeger AM, Gallagher SJ, Girerd J, Coleman SM, Dzau VJ, Cooke JP (1992) L-arginine improves endothelium dependant vasodilation in hypercholesterolemic patients. J Clin Invest 90: 1248-1253
8. Drexler H, Zeiher AM, Meinzer K, Just H (1991) Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 338 (i): 1546-1550
9. Dubois-Rande JL, Zelinsky R, Roudot F, Chabrier PE, Castaignae A, Geschwind H, Adnot S (1992) Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol 70: 1269-1275
10. Feelisch M (1991) The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 17: S25-S33
11. Flavahan NA (1992) Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 85: 1927-1938
12. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO (1994) Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 90: 35-41
13. Grodzińska L, Hafner G, Darius H (1990) Effect of molsidomine on t-PA and PAI activity in man: a double-blind, placebo-controlled study. Thromb Haemostas 64: 485
14. Grodzińska L, Kostka-Tra̧bka E, Bieroń K, Srawiński M, Goszcz A, Ochmański W (1991) Therapeutic effect of molsidomine, NO-donor, in patients with atherosclerosis obliterans of the lower limbs. J Drug Dev 4: 39-46
15. Gryglewski RJ (1990) Nitric oxide and atherosclerosis. Thromb Haemorrh Disorders 2: 1-9
16. Gryglewski RJ (1993) Interactions between nitric oxide and prostacyclin. Semin Thromb Haemostas 19: 158-166
17. Gryglewski RJ, Świȩs J (1995) Streptokinase-prostacyclin-nitric oxide: in vivo interactions. In: Samulesson B et al (eds) Advances in prostaglandin, thromboxane and leukotriene research, vol 23. Raven Press, New York, pp 479-484
18. Harima A, Shimizu H, Takagi H (1991) Analgesic effect of L-arginine in patients with persistent pain. Europ Neuropsychopharmacol 1:529-533
19. Halimet P, Pang SC, Tremblay J (1989) Atrial natriuretic factor-induced aggression of cyclic guanosine 3′5′-monophosphate in cultured vascular smooth muscle and endothelial cells. J Br Chem 264: 12364-12369
20. Hishikama K, Nakaki T, Tsuda M, Esumi H, Ofshima H. Suzuki H, Saruta T, Kato R (1992) Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 33: 41-48
21. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Inoi T, Marumo F (1992) L-arginine infusion induces hypertension and diuresis (natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic cGMP) in humans. Clin Exp Pharmacol Physiol 19: 619-625
22. Kaulla von KN, Schultz RL (1958) Method for evaluation of human fibrinolysis. Am J Clin Pathol 29: 104-112
23. Korbut R, Lidbury PS, Vane JR (1990) Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodilators. Lancet 335 (ii): 669
24. Mangiafico RA, Malatino LS, Santonocito M, Spada RS, Polizzi G, Stancanelli B, Leonardi C, Tanoburmo G (1993) Atrial natriuretic peptide response to postural changes and upright exercise in patients with venous valvular insufficiency. Int Angiology 12: 29-33
25. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142
26. Naruse K, Shimizu K, Muramatsu M, Toki Y, Miyazaki Y, Okumura K, Hashimoto H, Ito T (1994) Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. Arterioscler Thromb 14: 746-752
27. Rubanyi GM (1991) Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine. Circulation 83: 118-120
28. Radziszewski W, Surdacki A, Vuorinen P, Vapaatalo H. Saari M, Uusitolo A, Ruskoako H, Dubiel JS, Gryglewski RJ (1993) Plasma ANP and cyclic GMP after physical exercise in patients with mitral valve disease and in healthy subjects. Int J Cardiol 40: 203-209
29. Taguchi J, Abe J, Okazaki H, Takuwa Y, Kurokawa K (1993) L-arginine inhibits neointimal formation following balloon injury. Life Sci 53: PL387-392
30. Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii: 997-1000
31. Wu KK, Hoak JC (1974) A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet ii: 924-926